FAT jabs are being lined up as a cancer-beating super weapon as research shows they halve the risk of developing the disease.
Users had a lower danger than those who had slimming — even if they did not lose as much , a study found.
experts now want to test tens of thousands of people in a crucial clinical trial..
They believe the effects on inflammation, hormones and chemicals in the blood might offer added protection on top of the benefits of
Dr Matthew Harris, of the Manchester Cancer Research Centre, said: “Injectable weight loss medications give a genuinely promising possible option for cancer prevention in the future.”;;
The study compared 3,200 patients who lost weight with GLP-1 injections with 3,200 who had surgery.
Follow-up tests showed the cancer rate in surgical patients compared with jab patients.
Study author Dr Yael Wolff Sagy, of Clalit Health Services in Israel, said: “When we took into account the differences in weight reduction, we found the jabs were 41 per cent more effective at preventing cancer.
“This indicates there is an additional mechanism beyond simple weight loss. We believe this effect may come from reducing inflammation.
“This is potentially very exciting news for patients at high risk of obesity-related cancer and possibly other cancers.”;;
Dr Harris and dozens of international researchers told the European Congress on that a trial pitting the jabs against cancer should be a priority.
